Corporate Giving - Gilead Sciences supports community organizations with programs that expand disease awareness, prevention and early intervention to advance health equity in underserved communities.
Funder: Gilead Sciences
Due Dates: At least six weeks before the activity starts (Funding requests)
Funding Amounts: No limit on requested funding; request the amount needed for the project
Summary: Supports community-informed programs that improve awareness, prevention, early intervention and health equity across Gilead’s therapeutic focus areas.
Key Information: Only tax-exempt nonprofits are eligible; clinical studies are not supported.
Gilead Sciences’ Corporate Giving program partners with organizations serving communities disproportionately affected by disease, particularly people left out of traditional healthcare systems. It supports community-informed, data-driven work that expands awareness, strengthens engagement and connects people to prevention services and early intervention. Priorities include strengthening healthcare infrastructure, expanding education, advancing health equity, increasing diversity in clinical trials and improving access to medicines.
Funding requests may address HIV, liver disease, oncology or chronic inflammatory diseases. Gilead prioritizes initiatives with meaningful outcomes and organizations able to deliver the specific services proposed. Alongside grants, it sponsors selected events and conferences in the United States and internationally that raise awareness and support organizations working in its therapeutic areas. It also supports local communities where it operates.